An important facet of divisional activity is an exceptional program of basic, translational, and clinical research directed at understanding fundamental disease mechanisms as well as exploring new approaches to diagnosis and treatment. We have many collaborative links with other programs in the School of Medicine.
At the Division of Rheumatology, we are focused in the studies of:
- Clinical trials for systemic sclerosis including skin, pulmonary intestinal lung disease, pulmonary hypertension, Raynaud's and digital ulcers
- Interstitial lung disease in connective tissue diseases particularly scleroderma and myositis
- Scleroderma in African Americans
- Immune medicated sensory hearing loss
- Rheumatoid Arthritis, antitumor necrosis factor withdrawal trial
- Neuroimmune regulation of mucosal function in chronic fatigue syndrome and Gulf War syndrome